Veronika Kondev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Veronika Kondev has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Sachin Patel
Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago IL 60611 USA
3 shared publications - Eric J. Nestler
Icahn School of Medicine at Mount Sinai
2 shared publications Gaurav Bedse
Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA
2 shared publicationsRita Futamura
2 shared publicationsAdam Ripp
1 shared publicationAlexa LaBanca
1 shared publication
Latest Publications
- 18 November 2026
- Published by Elsevier in Biological Psychiatry
Cortical astrocytes bidirectionally control stress adaptability
- 18 November 2026
- Published by Elsevier in Biological Psychiatry
Cortical astrocytes bidirectionally control stress adaptability
- Open Access
- 17 December 2025
- Vol. 11 (51) , eaea2419
Astrocytic CREB regulates transcriptomic, neuronal, and behavioral responses to cocaine.
Emerging evidence increasingly indicates that astrocytes are involved in neuropsychiatric disorders, including addiction, but the cocaine-induced astrocyte transcriptome has yet to be investigated. We performed RNA sequencing on whole-cell sorted astrocytes from the nucleus accumbens and bioinformatically characterized the astrocyte transcriptome following cocaine self-administration in male mice. We found that astrocytes exhibit robust and contextually specific transcriptional signatures that implicate adenosine 3',5'-monophosphate response element-binding protein (CREB) as a cocaine-induced transcriptional regulator in astrocytes. Cleavage under targets and release using nuclease sequencing (CUT&RUN) revealed increased astrocytic CREB DNA binding in response to cocaine. Viral-mediated manipulation of nucleus accumbens astrocytic CREB activity in combination with addiction-related behaviors revealed that astrocytic CREB increases the rewarding and reinforcing properties of cocaine. Furthermore, we identified potential molecular mechanisms of astrocytic CREB's influence through modulating astrocytic calcium dynamics and selectively increasing D1-type medium spiny neuronal activity.
- 17 December 2025
- Vol. 11 (51) , eaea2419
Open AccessAstrocytic CREB regulates transcriptomic, neuronal, and behavioral responses to cocaine.
Emerging evidence increasingly indicates that astrocytes are involved in neuropsychiatric disorders, including addiction, but the cocaine-induced astrocyte transcriptome has yet to be investigated. We performed RNA sequencing on whole-cell sorted astrocytes from the nucleus accumbens and bioinformatically characterized the astrocyte transcriptome following cocaine self-administration in male mice. We found that astrocytes exhibit robust and contextually specific transcriptional signatures that implicate adenosine 3',5'-monophosphate response element-binding protein (CREB) as a cocaine-induced transcriptional regulator in astrocytes. Cleavage under targets and release using nuclease sequencing (CUT&RUN) revealed increased astrocytic CREB DNA binding in response to cocaine. Viral-mediated manipulation of nucleus accumbens astrocytic CREB activity in combination with addiction-related behaviors revealed that astrocytic CREB increases the rewarding and reinforcing properties of cocaine. Furthermore, we identified potential molecular mechanisms of astrocytic CREB's influence through modulating astrocytic calcium dynamics and selectively increasing D1-type medium spiny neuronal activity.
- Open Access
- 24 February 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (4) , 1728-1742
An endocannabinoid-regulated basolateral amygdala–nucleus accumbens circuit modulates sociability
Deficits in social interaction (SI) are a core symptom of autism spectrum disorders (ASDs); however, treatments for social deficits are notably lacking. Elucidating brain circuits and neuromodulatory signaling systems that regulate sociability could facilitate a deeper understanding of ASD pathophysiology and reveal novel treatments for ASDs. Here we found that in vivo optogenetic activation of the basolateral amygdala–nucleus accumbens (BLA-NAc) glutamatergic circuit reduced SI and increased social avoidance in mice. Furthermore, we found that 2-arachidonoylglycerol (2-AG) endocannabinoid signaling reduced BLA-NAc glutamatergic activity and that pharmacological 2-AG augmentation via administration of JZL184, a monoacylglycerol lipase inhibitor, blocked SI deficits associated with in vivo BLA-NAc stimulation. Additionally, optogenetic inhibition of the BLA-NAc circuit markedly increased SI in the Shank3B–/– mouse, an ASD model with substantial SI impairment, without affecting SI in WT mice. Finally, we demonstrated that JZL184 delivered systemically or directly to the NAc also normalized SI deficits in Shank3B–/– mice, while ex vivo JZL184 application corrected aberrant NAc excitatory and inhibitory neurotransmission and reduced BLA-NAc–elicited feed-forward inhibition of NAc neurons in Shank3B–/– mice. These data reveal circuit-level and neuromodulatory mechanisms regulating social function relevant to ASDs and suggest 2-AG augmentation could reduce social deficits via modulation of excitatory and inhibitory neurotransmission in the NAc.
- 24 February 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (4) , 1728-1742
Open AccessAn endocannabinoid-regulated basolateral amygdala–nucleus accumbens circuit modulates sociability
Deficits in social interaction (SI) are a core symptom of autism spectrum disorders (ASDs); however, treatments for social deficits are notably lacking. Elucidating brain circuits and neuromodulatory signaling systems that regulate sociability could facilitate a deeper understanding of ASD pathophysiology and reveal novel treatments for ASDs. Here we found that in vivo optogenetic activation of the basolateral amygdala–nucleus accumbens (BLA-NAc) glutamatergic circuit reduced SI and increased social avoidance in mice. Furthermore, we found that 2-arachidonoylglycerol (2-AG) endocannabinoid signaling reduced BLA-NAc glutamatergic activity and that pharmacological 2-AG augmentation via administration of JZL184, a monoacylglycerol lipase inhibitor, blocked SI deficits associated with in vivo BLA-NAc stimulation. Additionally, optogenetic inhibition of the BLA-NAc circuit markedly increased SI in the Shank3B–/– mouse, an ASD model with substantial SI impairment, without affecting SI in WT mice. Finally, we demonstrated that JZL184 delivered systemically or directly to the NAc also normalized SI deficits in Shank3B–/– mice, while ex vivo JZL184 application corrected aberrant NAc excitatory and inhibitory neurotransmission and reduced BLA-NAc–elicited feed-forward inhibition of NAc neurons in Shank3B–/– mice. These data reveal circuit-level and neuromodulatory mechanisms regulating social function relevant to ASDs and suggest 2-AG augmentation could reduce social deficits via modulation of excitatory and inhibitory neurotransmission in the NAc.
- Open Access
- 1 November 2019
- Published by Elsevier in Neurobiology of Stress
- Vol. 11, 100190
Cyclooxygenase-2 inhibition reduces anxiety-like behavior and normalizes enhanced amygdala glutamatergic transmission following chronic oral corticosterone treatment
- 1 November 2019
- Published by Elsevier in Neurobiology of Stress
- Vol. 11, 100190
Open AccessCyclooxygenase-2 inhibition reduces anxiety-like behavior and normalizes enhanced amygdala glutamatergic transmission following chronic oral corticosterone treatment
- 1 May 2016
- Published by Elsevier in Neuroscience Letters
- Vol. 622, 78-82
PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux
- 1 May 2016
- Published by Elsevier in Neuroscience Letters
- Vol. 622, 78-82
PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux